Differences in radiation, cisplatin, and cetuximab sensitivity between subpopulations of head and neck cancer cells

被引：0
|
作者：
Nilsson, C. [1 ]
La Fleur, L. [1 ]
Roberg, K. [1 ]
机构：
[1] Linkoping Univ Hosp, S-58185 Linkoping, Sweden
来源：
EJC SUPPLEMENTS | 2010年 / 8卷 / 05期
关键词：
D O I：
10.1016/S1359-6349(10)71219-2
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
418
引用
收藏
页码：107 / 107
页数：1
相关论文
共 50 条
  • [31] Aprepitant in weekly cisplatin with radiation in head and neck cancer: Is it required?
    D'souza, Hollis
    Noronha, Vanita
    Patil, Vijay Maruti
    Joshi, Amit
    Menon, Nandini Sharrel
    Prabhash, Kumar
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [32] Cetuximab and radiotherapy for head and neck cancer
    Posner, MR
    Wirth, LJ
    NEW ENGLAND JOURNAL OF MEDICINE, 2006, 354 (06) : 634 - 636
  • [33] More on cetuximab in head and neck cancer
    Mell, Loren K.
    Weichselbaum, Ralph R.
    NEW ENGLAND JOURNAL OF MEDICINE, 2007, 357 (21) : 2201 - 2202
  • [34] ABT-199 and cetuximab in combination with photon radiation in head and neck cancer stem cells.
    Espenel, S.
    Guy, J. B.
    Wozny, A. S.
    Vallard, A.
    Louati, S.
    Lauret, A.
    Simonet, S.
    Ardail, D.
    Alphonse, G.
    Rancoule, C.
    Rodriguez-Lafrasse, C.
    Magne, N.
    RADIOTHERAPY AND ONCOLOGY, 2018, 127 : S1263 - S1264
  • [35] Antisense cyclin D1 enhances sensitivity of head and neck cancer cells to cisplatin
    Wang, MB
    Yip, HT
    Srivatsan, ES
    LARYNGOSCOPE, 2001, 111 (06) : 982 - 988
  • [36] Vandetanib Restores Head and Neck Squamous Cell Carcinoma Cells' Sensitivity to Cisplatin and Radiation In Vivo and In Vitro
    Sano, Daisuke
    Matsumoto, Fumihiko
    Valdecanas, David R.
    Zhao, Mei
    Molkentine, David P.
    Takahashi, Yoko
    Hanna, Ehab Y.
    Papadimitrakopoulou, Vali
    Heymach, John
    Milas, Luka
    Myers, Jeffrey N.
    CLINICAL CANCER RESEARCH, 2011, 17 (07) : 1815 - 1827
  • [37] Chemoradiation for locally advanced head and neck cancers: Cetuximab or cisplatin?
    Mazeron, Jean-Jacques
    BULLETIN DU CANCER, 2016, 103 (04) : 319 - 319
  • [38] MALAT1 Decreases the Sensitivity of Head and Neck Squamous Cell Carcinoma Cells to Radiation and Cisplatin
    Kangboonruang, Kitsada
    Wongtrakoongate, Patompon
    Lertsuwan, Kornkamon
    Khachonkham, Suphalak
    Changkaew, Pimolpun
    Tangboonduangjit, Puangpen
    Siripoon, Teerada
    Ngamphaiboon, Nuttapong
    Chairoungdua, Arthit
    ANTICANCER RESEARCH, 2020, 40 (05) : 2645 - 2655
  • [39] Cisplatin (CDDP) and radiation versus cetuximab (Cx) and radiation in locally advanced head and neck squamous cell cancer (SCHNC): A retrospective review.
    Peddi, Prakash
    Shi, Runhua
    Panu, Lori
    Ampil, Fred
    Nathan, Cherie-Ann
    Armaghany, Tannaz
    Mills, Glenn Morris
    Jafri, Syed Hasan Raza
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [40] Comparison of cisplatin (CDDP) and radiation (RT) to cetuximab (C) and RT for locally advanced head and neck cancer (LAHNC): A preliminary analysis
    Koutcher, L.
    Fury, M.
    Wolden, S.
    Zhang, Z.
    Mo, Q.
    Zelefsky, M.
    Kraus, D.
    Sherman, E.
    Pfister, D.
    Lee, N.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
12345